πŸ‡ΊπŸ‡Έ FDA
Patent

US 12351633

PD-1 and PD-L1 binding agents

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 12351633 (PD-1 and PD-L1 binding agents) held by Orionis Biosciences, Inc expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P35/00